MM

Mohammad Mujeeb Ur Rahman

Active Director Designated Partner DIN 11778046
DIN 11778046 First appointment Jun 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohammad Mujeeb Ur Rahman

Mohammad Mujeeb Ur Rahman is a Designated Partner at Rmsprime Care Polyclinic, Pharmacy And Diagnostic Center Llp (since 2026).

DIN 11778046
Primary Designation Designated Partner
First Appointment 18 Jun 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner18 Jun 20262026Active

Board colleagues of Mohammad Mujeeb Ur Rahman

Directorship timeline

Open interactive timeline →
Rmsprime Care Polyclinic, Pharmacy And Diagnostic Center Llp
Premium access

Shareholding and investment profile for Mohammad Mujeeb Ur Rahman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohammad Mujeeb Ur Rahman

Mohammad Mujeeb Ur Rahman currently holds 1 directorship: Rmsprime Care Polyclinic, Pharmacy And Diagnostic Center Llp (Designated Partner, since 18 Jun 2026).

Mohammad Mujeeb Ur Rahman was first appointed on 18 Jun 2026 as Designated Partner at Rmsprime Care Polyclinic, Pharmacy And Diagnostic Center Llp.

The current boards of Mohammad Mujeeb Ur Rahman's companies include Abdur Raheem Mohammed (Rmsprime Care Polyclinic, Pharmacy And Diagnostic Center Llp), Mohammad Shafeeq Thahir (Rmsprime Care Polyclinic, Pharmacy And Diagnostic Center Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available